Senhwa Competitors

Stocks Taiwan . 
Stock . Senhwa Biosciences
6492 Stock  TWD 59.00  2.10  3.44%   
Senhwa Biosciences competes with Medigen Biotechnology, Orient Europharma, and Syngen Biotech; as well as few others. The company operates under Healthcare sector and is part of Biotechnology industry. Analyzing Senhwa Biosciences competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Senhwa Biosciences to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Senhwa Biosciences Correlation with its peers.

Senhwa Biosciences vs Syngen Biotech Correlation

Weak diversification

The correlation between Senhwa Biosciences and 8279 is 0.37 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Senhwa Biosciences and 8279 in the same portfolio, assuming nothing else is changed.

Moving against Senhwa Stock

  0.636712 Ever Supreme BioPairCorr
  0.554162 PharmaEnginePairCorr
  0.514147 TaiMed BiologicsPairCorr
Hype
Prediction
LowEstimatedHigh
55.9759.0062.03
Details
Intrinsic
Valuation
LowRealHigh
53.1065.0568.08
Details
Naive
Forecast
LowNextHigh
63.5466.5769.59
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
34.3448.1962.04
Details

Senhwa Biosciences Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Senhwa Biosciences and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Senhwa and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Senhwa Biosciences does not affect the price movement of the other competitor.

High positive correlations

8279
+ 0.8
6610
6794
+ 0.76
3176
1295
+ 0.74
4120
8279
+ 0.59
4120
8279
+ 0.56
6657
8279
+ 0.54
1295
  

High negative correlations

1295
- 0.87
6794
1295
- 0.68
3176
4120
- 0.66
6794
4120
- 0.58
3176
8279
- 0.48
3176
8279
- 0.47
6794

Risk-Adjusted Indicators

There is a big difference between Senhwa Stock performing well and Senhwa Biosciences Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Senhwa Biosciences' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Senhwa Biosciences Competitive Analysis

The better you understand Senhwa Biosciences competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Senhwa Biosciences' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Senhwa Biosciences' competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
6492 6657 3176 7754 6610 6794 4120 1295 8279
 3.44 
 59.00 
Senhwa
 3.33 
 55.80 
Energenesis
 0.30 
 32.75 
Medigen
 0.90 
 49.75 
7754
 1.22 
 20.20 
TWi
 0.22 
 89.30 
UnicoCell
 0.90 
 44.85 
Orient
 2.34 
 83.40 
Synbio
 0.75 
 132.50 
Syngen
Market Volatility
(90 Days Market Risk)
Very steady
Very steady
Very steady
Very steady
Somewhat reliable
Very steady
Very steady
Very steady
Very steady
Market Performance
(90 Days Performance)
Good
Fair
Fair
Mild
Soft
Solid
Weakest
Weakest
Weakest
Odds of Financial Distress
(Probability Of Bankruptcy)
Small
Unknown
Small
Unknown
Unknown
Unknown
High
Unknown
Low
Current Valuation
(Equity Enterprise Value)
Under Valued
Over Valued
Fairly Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Fairly Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Strong Buy
Strong Sell
Cautious Hold
Strong Sell
Strong Sell
Hold
Strong Sell
Strong Sell
Hold
Current Ratio
38.14
N/A
N/A
N/A
N/A
N/A
N/A
N/A
1.89
Net Asset
N/A
N/A
8.2 B
N/A
N/A
N/A
9.4 B
N/A
N/A
Profit Margin
N/A
N/A
-0.0804
N/A
N/A
N/A
-0.0197
N/A
14.8
EBITDA
(373.96 M)
N/A
1.35 B
N/A
N/A
N/A
313.89 M
N/A
275.24 M
Current Valuation
9.33 B
N/A
2.9 B
N/A
N/A
N/A
5.9 B
N/A
3.58 B
Price To Book
5.03
N/A
2.01
N/A
N/A
N/A
1.07
N/A
3.79
Operating Margin
N/A
N/A
0.0172
N/A
N/A
N/A
-0.0086
N/A
17.76
Beta
0.42
N/A
0.99
N/A
N/A
N/A
0.4
N/A
1.02
Number Of Employees
9
N/A
18
N/A
N/A
N/A
21
N/A
9
Shares Outstanding
89.62 M
N/A
139.45 M
N/A
N/A
N/A
86.75 M
N/A
23.1 M
Cash Flow From Operations
(286.34 M)
N/A
518.12 M
N/A
N/A
N/A
77.65 M
N/A
171.18 M
Annual Yield
N/A
N/A
N/A
N/A
N/A
N/A
0.0235
N/A
N/A
Total Debt
17.59 M
N/A
470.77 M
N/A
N/A
N/A
1.68 B
N/A
251.18 M
Return On Equity
-25.12
N/A
-0.0022
N/A
N/A
N/A
-0.0268
N/A
21.75
Z Score
N/A
N/A
5.4
N/A
N/A
N/A
0.6
N/A
8.4
Return On Asset
-15.79
N/A
0.0036
N/A
N/A
N/A
-0.0027
N/A
10.11
Book Value Per Share
24.95
N/A
18.24
N/A
N/A
N/A
33.54
N/A
39.33
Total Asset
N/A
N/A
8.2 B
N/A
N/A
N/A
9.4 B
N/A
N/A
Debt To Equity
0.008
N/A
N/A
N/A
N/A
N/A
N/A
N/A
27.6
Last Dividend Paid
N/A
N/A
N/A
N/A
N/A
N/A
0.85
N/A
2.5
Shares Owned By Institutions
1.0
N/A
2.8
N/A
N/A
N/A
0.45
N/A
N/A
Market Capitalization
11.25 B
N/A
4.42 B
N/A
N/A
N/A
3.13 B
N/A
3.54 B
Price To Earning
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
18.78
Price To Sales
N/A
N/A
1.66
N/A
N/A
N/A
0.68
N/A
2.85
Net Income
(358.44 M)
N/A
(52.61 M)
N/A
N/A
N/A
120.17 M
N/A
183.85 M
Earnings Per Share
-4.38
N/A
-0.5
N/A
N/A
N/A
0.54
N/A
7.93
Shares Owned By Insiders
29.79
N/A
25.17
N/A
N/A
N/A
65.1
N/A
N/A
Revenue
600 K
N/A
3.92 B
N/A
N/A
N/A
4.77 B
N/A
1.24 B
Cash And Equivalents
2.21 B
N/A
N/A
N/A
N/A
N/A
N/A
N/A
110.77 M
Cash Per Share
24.67
N/A
N/A
N/A
N/A
N/A
N/A
N/A
4.8
Gross Profit
351 K
N/A
2.55 B
N/A
N/A
N/A
2.15 B
N/A
377.38 M
Day Typical Price
59.93
56.0
33.22
49.7
20.23
89.17
44.72
83.97
133.67
Accumulation Distribution
0.0516
0.0722
0.041
0.0443
0.0292
0.0134
0.0111
0.02
0.033
Market Facilitation Index
3.2
4.2
1.4
2.25
0.6
1.2
0.5
1.7
4.5
Daily Balance Of Power
(0.66)
0.4286
(0.07)
(0.20)
(0.42)
0.1667
0.8
(1.18)
(0.22)
Period Momentum Indicator
(2.10)
1.8
(0.10)
(0.45)
(0.25)
0.2
0.4
(2.00)
(1.00)
Rate Of Daily Change
0.97
1.03
1.0
0.99
0.99
1.0
1.01
0.98
0.99
Day Median Price
60.4
56.1
33.45
49.68
20.25
89.1
44.65
84.25
134.25
Price Action Indicator
(2.45)
0.6
(0.75)
(0.15)
(0.18)
0.3
0.4
(1.85)
(2.25)
Relative Strength Index
69.89
67.02
56.3
N/A
N/A
63.77
50.55
37.05
59.95
Coefficient Of Variation
674.78
926.1
1098.88
1501.0
2474.75
451.14
(1,950)
(364.89)
(33,712)
Mean Deviation
2.02
2.01
1.21
1.88
2.67
1.28
0.7355
1.25
1.11
Jensen Alpha
0.4061
0.3543
0.1575
0.2367
0.1967
0.4439
(0.06)
(0.45)
(0.03)
Total Risk Alpha
0.2247
0.1009
0.0266
(0.02)
(0.14)
0.2885
(0.13)
(0.56)
(0.13)
Sortino Ratio
0.1478
0.1037
0.062
0.0781
0.0451
0.2632
N/A
N/A
N/A
Downside Variance
6.87
6.27
2.75
4.09
6.7
2.05
N/A
N/A
N/A
Standard Deviation
3.03
2.97
1.8
3.29
4.41
1.98
1.02
1.58
1.63
Kurtosis
3.8
3.05
4.14
17.55
11.87
7.82
1.5
0.6993
3.55
Potential Upside
5.7
5.35
3.3
3.37
5.47
3.02
1.47
1.82
2.38
Treynor Ratio
0.6914
(0.37)
(2.25)
(0.39)
(0.30)
(1.39)
0.6769
(5.89)
(0.04)
Maximum Drawdown
13.44
17.79
11.21
22.67
24.76
13.5
5.44
6.44
8.76
Variance
9.17
8.83
3.25
10.83
19.42
3.91
1.04
2.5
2.66
Market Risk Adjusted Performance
0.7014
(0.36)
(2.24)
(0.38)
(0.29)
(1.38)
0.6869
(5.88)
(0.03)
Risk Adjusted Performance
0.1152
0.086
0.072
0.0562
0.0377
0.1673
(0.03)
(0.19)
0.0034
Skewness
1.03
0.9398
1.13
3.42
2.9
1.91
(0.69)
0.2229
0.6689
Semi Deviation
2.03
2.08
1.41
1.72
2.31
0.9137
N/A
N/A
N/A
Information Ratio
0.1279
0.0874
0.057
0.048
0.0265
0.1906
(0.11)
(0.31)
(0.04)
Value At Risk
(3.38)
(3.84)
(2.67)
(3.14)
(3.72)
(1.91)
(1.79)
(2.54)
(2.31)
Expected Short fall
(2.27)
(2.51)
(1.28)
(2.47)
(4.48)
(1.60)
N/A
N/A
N/A
Downside Deviation
2.62
2.5
1.66
2.02
2.59
1.43
N/A
N/A
N/A
Semi Variance
4.14
4.33
2.0
2.96
5.32
0.8348
N/A
N/A
N/A

Senhwa Biosciences Competition Performance Charts

Five steps to successful analysis of Senhwa Biosciences Competition

Senhwa Biosciences' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Senhwa Biosciences in relation to its competition. Senhwa Biosciences' competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Senhwa Biosciences in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Senhwa Biosciences' competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Senhwa Biosciences, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Senhwa Biosciences position

In addition to having Senhwa Biosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Entertainment Thematic Idea Now

Entertainment
Entertainment Theme
Companies from entertainment industry including show business, news and media. The Entertainment theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Entertainment Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Senhwa Stock Analysis

When running Senhwa Biosciences' price analysis, check to measure Senhwa Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Senhwa Biosciences is operating at the current time. Most of Senhwa Biosciences' value examination focuses on studying past and present price action to predict the probability of Senhwa Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Senhwa Biosciences' price. Additionally, you may evaluate how the addition of Senhwa Biosciences to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY